Plain-English plan summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Leidos Biomedical Research, Inc. Capital Accumulation Plan is a benefit plan reported by Leidos Biomedical Research, Inc. under EIN 33-0653185 and plan number 003. The latest loaded filing year is 2023. The filing reports 2,942 participants and $305,047,981 in end-of-year plan assets, where available in the loaded dataset.
Reported financial statement (2023 · Schedule H)
Net assets
- Total assets (EOY)
- $305,047,981
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $305,047,981
- Net assets (BOY)
- $238,526,927
Income & contributions
- Employer contributions
- $8,849,582
- Participant contributions
- $24,315,100
- Total contributions
- $35,838,228
- Total income / additions
- $80,331,778
Expenses & distributions
- Benefits paid
- $13,742,252
- Administrative expenses
- $69,103
- Total expenses
- $13,810,724
- Net increase / (decrease)
- $66,521,054